This is a comprehensive review of the literature on drug interactions (DIs) between atypical
antipsychotics and anti-infective agents that focuses on those DIs with the potential to be …

Introduction Antipsychotics are widely used and often in combination with other drugs,
thereby frequently subjected to drug-drug interactions. This review will provide a summary of …

Psychotropic medications are frequently co-prescribed with antiretroviral therapy (ART),
owing to a high prevalence of psychiatric illness within the population living with HIV, as well …

Identifying and reducing the risk of antipsychotic drug interactions Page 1 Adrug interaction
occurs when the effects of one drug are altered by the presence of another substance. The …

Antipsychotics are the mainstay of treatment for psychotic disorders. Both the newer atypical
antipsychotics and their more traditional counterparts are subject to drug-drug interactions …

Objectives: While not always clinically significant, patients with schizophrenia may be at risk
for drug (drug–interactions (DDIs) with second-generation antipsychotics. Second …

Introduction: Pharmacokinetic and pharmacodynamic drug interactions (DIs) can occur
between antiepileptics (AEDs) and second-generation antipsychotics (SGAPs). Some AED …

Antipsychotic drugs can be of great benefit in a range of psychiatric disorders, including
schizophrenia and bipolar disorder, but all are associated with a wide range of potential …

Drug-drug interactions (DDIs) are a concern for the prescriber because they have the
potential for causing untoward outcomes for everyone involved: morbidity for the patient …

Atypical antipsychotics [also known as second-generation antipsychotics (SGAs)] have
become a mainstay therapeutic treatment intervention for patients with schizophrenia …